BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32997377)

  • 1. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.
    Krotulski AJ; Cannaert A; Stove C; Logan BK
    Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and
    Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
    ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD
    Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP
    Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
    Erol Ozturk Y; Yeter O
    J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
    Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
    Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings.
    Goncalves R; Labadie M; Chouraqui S; Peyré A; Castaing N; Daveluy A; Molimard M
    Clin Toxicol (Phila); 2022 Apr; 60(4):458-463. PubMed ID: 34850659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples.
    Gu K; Qin S; Zhang Y; Zhang W; Xin G; Shi B; Wang J; Wang Y; Lu J
    J Pharm Biomed Anal; 2022 Oct; 220():114985. PubMed ID: 35985137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays.
    Grafinger KE; Vandeputte MM; Cannaert A; Ametovski A; Sparkes E; Cairns E; Juchli PO; Haschimi B; Pulver B; Banister SD; Stove CP; Auwärter V
    Drug Test Anal; 2021 Jul; 13(7):1412-1429. PubMed ID: 33908179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists.
    Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL
    Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cannabinoid-like effects and pharmacokinetics of ADB-BICA, ADB-BINACA, ADB-4en-PINACA and MDMB-4en-PINACA in mice: A comparative study.
    Zhou F; Wang X; Tan S; Shi Y; Xie B; Xiang P; Cong B; Ma C; Wen D
    Addict Biol; 2024 Feb; 29(2):e13372. PubMed ID: 38380735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-MS Identification and Quantification of the Synthetic Cannabinoid MDMB-4en- PINACA in Cannabis-derived Material Seized in the Turin Metropolitan Area (Italy).
    Gerace E; Seganti F; Di Corcia D; Vincenti M; Salomone A
    Curr Pharm Des; 2022; 28(32):2618-2621. PubMed ID: 35658890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal Overdose with the Cannabinoid Receptor Agonists MDMB-4en-PINACA and 4F-ABUTINACA: A Case Report and Review of the Literature.
    Simon G; Kuzma M; Mayer M; Petrus K; Tóth D
    Toxics; 2023 Aug; 11(8):. PubMed ID: 37624178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of Synthetic Cannabinoid New Psychoactive Substances 4F-MDMB-BUTINACA and MDMB-4en-PINACA].
    Wang KD; Yuan XL; Zhang YR; Hu JJ; Cao FQ; Chen YS
    Fa Yi Xue Za Zhi; 2021 Aug; 37(4):505-510. PubMed ID: 34726003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances - A Swedish strategy to protect public health from harm.
    Bäckberg M; Vikingsson S; Strandberg J; Wall S; Åstrand A; Karlsson H; Persson M; Kronstrand R; Green H
    Forensic Sci Int; 2023 Jul; 348():111691. PubMed ID: 37116244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
    Gatch MB; Forster MJ
    Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases.
    Wagmann L; Stiller RG; Fischmann S; Westphal F; Meyer MR
    Arch Toxicol; 2022 Oct; 96(10):2755-2766. PubMed ID: 35788413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.